tiprankstipranks
Trending News
More News >
IGC Pharma (IGC)
:IGC
US Market

IGC Pharma (IGC) Financial Statements

Compare
1,000 Followers

IGC Pharma Financial Overview

IGC Pharma's market cap is currently $28.72M. The company's EPS TTM is $-0.02; its P/E ratio is -3.73; IGC Pharma is scheduled to report earnings on November 17, 2025, and the estimated EPS forecast is $-0.02. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 1.27M$ 1.34M$ 911.00K$ 397.00K$ 898.00K
Gross Profit$ 619.00K$ 733.00K$ -158.00K$ 194.00K$ -349.00K
Operating Income$ -7.45M$ -9.80M$ -11.57M$ -15.43M$ -8.72M
EBITDA$ -6.83M$ -9.16M$ -10.85M$ -14.37M$ -8.33M
Net Income$ -7.12M$ -13.00M$ -11.51M$ -15.02M$ -8.81M
Balance Sheet
Cash & Short-Term Investments$ 405.00K$ 1.20M$ 3.35M$ 10.46M$ 14.63M
Total Assets$ 8.75M$ 9.90M$ 17.18M$ 26.83M$ 35.87M
Total Debt$ 238.00K$ 348.00K$ 481.00K$ 611.00K$ 1.07M
Net Debt$ -167.00K$ -850.00K$ -2.71M$ -9.85M$ -13.47M
Total Liabilities$ 2.42M$ 2.58M$ 2.27M$ 2.94M$ 3.06M
Stockholders' Equity$ 6.33M$ 7.32M$ 14.91M$ 23.89M$ 32.80M
Cash Flow
Free Cash Flow$ -5.28M$ -5.71M$ -7.67M$ -8.23M$ -12.39M
Operating Cash Flow$ -4.79M$ -5.20M$ -7.05M$ -7.46M$ -10.80M
Investing Cash Flow$ -442.00K$ -317.00K$ -235.00K$ -742.00K$ 3.39M
Financing Cash Flow$ 4.45M$ 3.52M$ 100.00K$ 4.14M$ 14.69M
Currency in USD

IGC Pharma Earnings and Revenue History

IGC Pharma Debt to Assets

IGC Pharma Cash Flow

IGC Pharma Forecast EPS vs Actual EPS